Smith & Nephew plc (LON:SN) Receives Consensus Rating of “Hold” from Analysts

Smith & Nephew plc (LON:SN) has been assigned a consensus recommendation of “Hold” from the eight brokerages that are currently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is GBX 1,382.63.

SN has been the topic of a number of research analyst reports. Jefferies Financial Group restated a “buy” rating and issued a GBX 2,760 target price on shares of Smith & Nephew in a research note on Thursday, May 21st. Berenberg Bank restated a “hold” rating and issued a GBX 13 target price on shares of Smith & Nephew in a research note on Friday, May 1st. UBS Group restated a “neutral” rating and issued a GBX 1,300 target price on shares of Smith & Nephew in a research note on Tuesday, May 5th. Finally, Royal Bank Of Canada downgraded shares of Smith & Nephew to a “sector perform” rating and set a GBX 1,350 target price on the stock. in a research note on Thursday, May 7th.

Smith & Nephew Trading Up 1.3%

Shares of LON:SN opened at GBX 1,147 on Monday. The company has a market cap of £12.57 billion, a P/E ratio of 41.30, a price-to-earnings-growth ratio of 0.46 and a beta of 0.67. The firm’s 50 day moving average price is GBX 1,165.29 and its 200-day moving average price is GBX 1,223.26. The company has a debt-to-equity ratio of 62.90, a current ratio of 2.57 and a quick ratio of 0.84.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.